Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | SC291 |
Trade Name | |
Synonyms | SC 291|SC-291|Allogeneic HIP Anti-CD19 CAR-T Cells SC291 |
Drug Descriptions |
SC291 is an allogeneic chimeric antigen receptor (CAR) T-cell therapy targeting CD19, which may induce a cytotoxic immune response against CD19-expressing tumor cells (NCI Drug Dictionary). |
DrugClasses | CD19 Immune Cell Therapy 62 |
CAS Registry Number | NA |
NCIT ID | C200072 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
SC291 | SC291 | 0 | 1 |